Joan Serrano-Plana

Joan Serrano-Plana

Auto-generated profile, based on publicly available information

Joan Serrano-Plana

Institut de Química Computacional i Catàlisi (IQCC) Departament de Química, Universitat de Girona C/Mª Aurèlia Capmany 69 17003 Girona Catalonia Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2019 in Accounts of Chemical Research
Verified
Journal Article
Open access
ALAlexandria Deliz Liang
Alexandria Deliz Liang
JSJoan Serrano-Plana
Joan Serrano-Plana
RPRyan L. Peterson
Ryan L. Peterson
TWThomas R. Ward
Thomas R. Ward
Artificial metalloenzymes (ArMs) result from anchoring a metal-containing moiety within a macromolecular scaffold (protein or oligonucleotide). The resulting hybrid catalyst combines attractive features of both homogeneous catalysts and enzymes. This strategy includes the possibility of optimizing the reaction by both chemical (catalyst design) and genetic means leading to achievement of a novel degree of (enantio)selectivity, broadening of the substrate scope, or increased activity, among others. In the past 20 years, the Ward group has exploited, among others, the biotin–(strept)avidin technology to localize a catalytic moiety within a well-defined protein environment. Streptavidin has proven versatile for the implementation of ArMs as it offers the following features: (i) it is an extremely robust protein scaffold, amenable to extensive genetic manipulation and mishandling, (ii) it can be expressed in E. coli to very high titers (up to >8 g·L–1 in fed-batch cultures), and (iii) the cavity surrounding the biotinylated cofactor is commensurate with the size of a typical metal-catalyzed transition state. Relying on a chemogenetic optimization strategy, varying the orientation and the nature of the biotinylated cofactor within genetically engineered streptavidin, 12 reactions have been reported by the Ward group thus far. Recent efforts within our group have focused on extending the ArM technology to create complex systems for integration into biological cascade reactions and in vivo. With the long-term goal of complementing in vivo natural enzymes with ArMs, we summarize herein three complementary research lines: (i) With the aim of mimicking complex cross-regulation mechanisms prevalent in metabolism, we have engineered enzyme cascades, including cross-regulated reactions, that rely on ArMs. These efforts highlight the remarkable (bio)compatibility and complementarity of ArMs with natural enzymes. (ii) Additionally, multiple-turnover catalysis in the cytoplasm of aerobic organisms was achieved with ArMs that are compatible with a glutathione-rich environment. This feat is demonstrated in HEK-293T cells that are engineered with a gene switch that is upregulated by an ArM equipped with a cell-penetrating module. (iii) Finally, ArMs offer the fascinating prospect of “endowing organometallic chemistry with a genetic memory.” With this goal in mind, we have identified E. coli’s periplasmic space and surface display to compartmentalize an ArM, while maintaining the critical phenotype–genotype linkage. This strategy offers a straightforward means to optimize by directed evolution the catalytic performance of ArMs. Five reactions have been optimized following these compartmentalization strategies: ruthenium-catalyzed olefin metathesis, ruthenium-catalyzed deallylation, iridium-catalyzed transfer hydrogenation, dirhodium-catalyzed cyclopropanation and carbene insertion in C–H bonds. Importantly, >100 turnovers were achieved with ArMs in E. coli whole cells, highlighting the multiple turnover catalytic nature of these systems.

15 December 2015 in Journal of the American Chemical Society
Verified
Journal Article
Open access
JSJoan Serrano-Plana
Joan Serrano-Plana
WOWilliamson N. Oloo
Williamson N. Oloo
LALaura Acosta-Rueda
Laura Acosta-Rueda
KMKatlyn K. Meier
Katlyn K. Meier
Begoña VerdejoBegoña Verdejo
Begoña Verdejo
MCMiquel Costas
Miquel Costas
An unprecedentedly reactive iron species (2) has been generated by reaction of excess peracetic acid with a mononuclear iron complex [FeII(CF3SO3)2(PyNMe3)] (1) at cryogenic temperatures, and characterized spectroscopically. Compound 2 is kinetically competent for breaking strong C—H bonds of alkanes (BDE ≈ 100 kcal·mol–1) through a hydrogen-atom transfer mechanism, and the transformations proceed with stereoretention and regioselectively, responding to bond strength, as well as to steric and polar effects. Bimolecular reaction rates are at least an order of magnitude faster than those of the most reactive synthetic high-valent nonheme oxoiron species described to date. EPR studies in tandem with kinetic analysis show that the 490 nm chromophore of 2 is associated with two S = 1/2 species in rapid equilibrium. The minor component 2a (∼5% iron) has g-values at 2.20, 2.19, and 1.99 characteristic of a low-spin iron(III) center, and it is assigned as [FeIII(OOAc)(PyNMe3)]2+, also by comparison with the EPR parameters of the structurally characterized hydroxamate analogue [FeIII(tBuCON(H)O)(PyNMe3)]2+ (4). The major component 2b (∼40% iron, g-values = 2.07, 2.01, 1.95) has unusual EPR parameters, and it is proposed to be [FeV(O)(OAc)(PyNMe3)]2+, where the O—O bond in 2a has been broken. Consistent with this assignment, 2b undergoes exchange of its acetate ligand with CD3CO2D and very rapidly reacts with olefins to produce the corresponding cis-1,2-hydroxoacetate product. Therefore, this work constitutes the first example where a synthetic nonheme iron species responsible for stereospecific and site selective C—H hydroxylation is spectroscopically trapped, and its catalytic reactivity against C—H bonds can be directly interrogated by kinetic methods. The accumulated evidence indicates that 2 consists mainly of an extraordinarily reactive [FeV(O)(OAc)(PyNMe3)]2+ (2b) species capable of hydroxylating unactivated alkyl C—H bonds with stereoretention in a rapid and site-selective manner, and that exists in fast equilibrium with its [FeIII(OOAc)(PyNMe3)]2+ precursor.

22 June 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CKClaudia Kupper
Claudia Kupper
BMBhaskar Mondal
Bhaskar Mondal
JSJoan Serrano-Plana
Joan Serrano-Plana
IKIris Klawitter
Iris Klawitter
FNFrank Neese
Frank Neese
Franc MeyerFranc Meyer
Franc Meyer

24 July 2015 in Accounts of Chemical Research
Verified
Journal Article
Closed access
JSJoan Serrano-Plana
Joan Serrano-Plana
IGIsaac Garcia-Bosch
Isaac Garcia-Bosch
ACAnna Company
Anna Company
MCMiquel Costas
Miquel Costas

20 February 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RFRuixi Fan
Ruixi Fan
JSJoan Serrano-Plana
Joan Serrano-Plana
WOWilliamson N. Oloo
Williamson N. Oloo
ADApparao Draksharapu
Apparao Draksharapu
EPEstefanía Delgado Pinar
Estefanía Delgado Pinar
EMEckard Münck
Eckard Münck

26 May 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JSJoan Serrano-Plana
Joan Serrano-Plana
CRCorentin Rumo
Corentin Rumo
JRJohannes G. Rebelein
Johannes G. Rebelein
RPRyan Peterson
Ryan Peterson
MBMaxime Barnet
Maxime Barnet
TWThomas R. Ward
Thomas R. Ward